This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Other and unspecified disorders involving the immune mechanism, not elsewhere classified
D3_IMMUNEMECHANISMNAS
immune system disease: A disorder resulting from an abnormality in the immune system.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1054 |
4. Check minimum number of eventsNone |
1054 |
5. Include endpointsNone |
1054 |
6. Filter based on genotype QC (FinnGen only) |
1054 |
Control definitions (FinnGen only)
- Control exclude
- D3_IMMUNEMECHANISM
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Other and unspecified disorders involving the immune mechanism, not elsewhere classified
based on the number of shared cases.
Similar with more cases:
- Other disorders involving the immune mechanism, not elsewhere classified
- Certain disorders involving the immune mechanism
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1054 | 396 | 658 |
| Unadjusted period prevalence (%) | 0.23 | 0.13 | 0.29 |
| Median age at first event (years) | 48.12 | 42.07 | 51.76 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 936
- Matched controls
- 9361
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N08.2*D89.80
ICD-10 Finland
Immunoglobulin A (IgA) nephropathy
+∞
323.0
762
*
D89.80
ICD-10 Finland
Immunoglobulin A (IgA) deposits in organisms
+∞
284.3
258
*
N08.2
ICD-10 Finland
Glomerular disorders in blood diseases and disorders involving the immune mechanism
3148.8
271.4
249
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
62.9
268.3
310
73
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
70.1
263.9
299
62
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
103.6
254.9
273
37
A11CC03
ATC
alfacalcidol; systemic
51.7
216.6
260
69
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
91.3
214.3
234
34
Z94.0
ICD-10 Finland
Kidney transplant status
73.0
212.7
240
44
127
Kela drug reimbursment
Transplant complication
50.3
202.2
244
65
L04AA06
ATC
mycophenolic acid; systemic
51.1
200.3
241
63
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
22.3
196.0
298
192
A12AA04
ATC
calcium carbonate; oral
71.6
190.7
216
39
TK800
NOMESCO Finland
Hemodialysis
38.4
180.3
231
79
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
81.3
169.9
189
29
C03CA01
ATC
furosemide; systemic
7.4
155.6
474
1139
Z49.1
ICD-10 Finland
Extracorporeal dialysis
49.5
152.0
184
46
B03XA02
ATC
darbepoetin alfa; parenteral
47.7
151.7
185
48
137
Kela drug reimbursment
Uraemia requiring dialysis
106.3
147.6
159
18
205
Kela drug reimbursment
Chronic hypertension
6.8
145.2
481
1266
N18.8
ICD-10 Finland
Other chronic renal failure
26.3
140.3
199
95
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
48.4
138.2
168
42
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
77.1
138.0
155
24
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
13.4
134.2
250
248
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
105.4
132.4
143
16
KA1AE
NOMESCO Finland
Kidney ultrasound examination
31.6
131.1
176
68
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
7.7
127.7
345
658
N18.0
ICD-10 Finland
End-stage renal disease
45.9
122.9
151
39
B05DA
ATC
Isotonic solutions
117.0
122.6
131
13
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
+∞
121.6
114
*
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
54.7
117.9
140
30
Z49.0
ICD-10 Finland
Preparatory care for dialysis
56.6
115.2
136
28
Z49.2
ICD-10 Finland
Other dialysis
100.1
112.2
122
14
H02AB04
ATC
methylprednisolone; systemic
6.7
109.8
328
698
M04AA01
ATC
allopurinol; systemic
7.4
107.8
292
540
N03.9
ICD-10 Finland
Chronic nephritic syndrome, unspecified
158.7
107.7
112
8
R80
ICD-10 Finland
Isolated proteinuria
47.3
107.4
131
32
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
39.6
107.3
136
40
C08CA01
ATC
amlodipine; oral
4.7
101.7
497
1826
B05DB
ATC
Hypertonic solutions
112.0
101.4
109
11
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
13.6
98.0
178
159
L04AD01
ATC
ciclosporin; systemic
19.9
97.1
150
89
C09AA02
ATC
enalapril; systemic
5.3
94.4
350
943
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
30.1
88.0
119
45
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.0
87.6
568
2591
V03AE01
ATC
polystyrene sulfonate; oral
29.5
86.0
117
45
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
9.1
85.6
193
259
R31
ICD-10 Finland
Unspecified haematuria
6.7
84.5
241
461
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
4.3
81.7
394
1351
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
147.5
77.3
81
6
B03XA01
ATC
erythropoietin; parenteral
47.4
77.2
94
22
V03AE02
ATC
sevelamer; oral
63.7
75.2
87
15
N03.3
ICD-10 Finland
Chronic nephritic syndrome, diffuse mesangial proliferative glomerulonephritis
267.4
73.5
74
*
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
60.5
71.2
83
15
TK820
NOMESCO Finland
Peritoneal dialysis
104.8
71.1
77
8
C02AC05
ATC
moxonidine; oral
10.7
68.8
139
150
196
Kela drug reimbursment
Paricalcitol and cinacalcet
49.1
67.0
81
18
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
96.0
64.9
71
8
N19
ICD-10 Finland
Unspecified kidney failure
16.7
64.9
106
71
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
7.5
64.2
162
253
TPX10
NOMESCO Finland
Implantation of vascular injection port
12.6
62.2
115
103
D89.9
ICD-10 Finland
Disorder involving the immune mechanism, unspecified
+∞
61.1
58
*
L04AA01
ATC
[U] ciclosporin; systemic
19.0
59.9
93
54
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
7.6
57.1
142
215
R4110
NOMESCO Finland
Physiotherapy
3.4
56.4
362
1473
H05BX01
ATC
cinacalcet; oral
68.5
56.0
64
10
C09CA01
ATC
losartan; oral
3.6
54.9
309
1128
L04AX01
ATC
azathioprine; systemic
8.4
54.8
127
172
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
42.4
54.0
67
17
C07AG02
ATC
carvedilol; oral
7.8
52.7
128
186
N17.9
ICD-10 Finland
Acute renal failure, unspecified
9.9
52.7
110
124
ZX120
NOMESCO Finland
Intravenous
5.3
52.7
178
400
5828A
ICD-9 Finland
Chronic glomerulonephritis, With other specified pathological lesion in kidney[GLOMERULONEPHRITIS CHRONICA ALIA DEF,EI NEFR SDR]
536.3
52.0
51
*
Z3226
NOMESCO Finland
Physiotherapist
3.6
50.8
279
991
C08CA02
ATC
felodipine; oral
5.8
49.8
152
302
N08.2*D89.82
ICD-10 Finland
Nepropathy caused by deposition of the light chain of the immunoglobulins
+∞
48.3
46
*
N08.2*D69.0
ICD-10 Finland
Glomerular disorders in Henoch(-Schönlein) purpura
175.8
48.3
50
*
321
Kela drug reimbursment
Paricalcitol and cinacalcet
59.4
48.0
56
10
R50.9
ICD-10 Finland
Fever, unspecified
3.9
47.7
230
728
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
5.0
46.8
163
376
TJA33
NOMESCO Finland
Percutaneous introduction of peritoneal dialysis catheter
88.0
45.3
50
6
M10.9
ICD-10 Finland
Gout, unspecified
6.2
44.4
127
231
C08CA13
ATC
lercanidipine; oral
4.2
44.4
186
516
H02AB06
ATC
prednisolone; systemic
2.7
44.2
500
2817
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.6
43.6
167
424
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
49.9
43.4
52
11
N39.1
ICD-10 Finland
Persistent proteinuria, unspecified
44.8
41.7
51
12
TPH04
NOMESCO Finland
Cathetrisation of vein
3.1
41.5
278
1118
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.3
41.0
166
443
V03AE03
ATC
lanthanum carbonate; oral
46.9
40.4
49
11
Z2446
NOMESCO Finland
Social worker
4.7
40.1
149
365
C09CA06
ATC
candesartan; oral
3.1
39.8
263
1044
WX408
NOMESCO Finland
General anesthesy, balanced
2.8
39.7
347
1647
D69.0
ICD-10 Finland
Allergic purpura
27.2
39.3
54
21
ZXE10
NOMESCO Finland
More than one and less than three hours
2.6
38.9
405
2125
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.4
38.4
219
779
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
16.6
37.8
61
39
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
19.1
36.6
56
31
N03.8
ICD-10 Finland
Chronic nephritic syndrome, other
131.9
36.0
38
*
U14
ICPC
Kidney symptom/complaint
18.8
35.7
55
31
RD210
NOMESCO Finland
NA
9.9
35.6
73
79
I10
ICD-10 Finland
Essential (primary) hypertension
2.4
35.2
526
3279
ZXA00
NOMESCO Finland
Right side
2.7
35.1
297
1364
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
5.6
34.5
106
209
K65.0
ICD-10 Finland
Acute peritonitis
17.8
34.5
54
32
WW200
NOMESCO Finland
Immunization
8.0
34.3
80
108
N082, D898
ICD-10 Finland
NA
+∞
33.5
32
*
C02CA01
ATC
prazosin; oral
15.7
33.5
55
37
58209
ICD-8 Finland
Chronic nephritis, Unspecified
121.0
32.9
35
*
ZXE20
NOMESCO Finland
More than three and less than five hours
3.1
32.0
198
736
TK810
NOMESCO Finland
Hemofiltration
21.9
31.6
46
22
3AC01
NOMESCO Finland
NA
16.3
31.5
51
33
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.0
31.4
135
376
A12AA12
ATC
[U] calcium acetate anhydrous; systemic
88.2
30.9
34
*
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
70.4
30.1
34
5
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.9
30.0
207
826
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.2
29.6
441
2663
N08.2*D57.8
ICD-10 Finland
Glomerular disorders in sickle-cell disorders
+∞
29.3
28
*
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
7.6
29.3
70
98
Z2221
NOMESCO Finland
Medical doctor
2.4
29.1
325
1702
C10AA05
ATC
atorvastatin; oral
2.3
28.6
368
2064
ZXD05
NOMESCO Finland
Urgent procedure
2.3
28.5
348
1902
M05BA04
ATC
alendronic acid; oral
5.2
28.3
92
193
Z3231
NOMESCO Finland
Registered nurse
2.4
28.2
316
1653
M01AE01
ATC
ibuprofen; systemic, rectal
0.4
28.2
572
7315
XW000
NOMESCO Finland
Bone marrow biopsy
5.9
28.1
81
147
KA9AE
NOMESCO Finland
Ultrasound examination transplanted kidney
66.1
28.1
32
5
BBA40
NOMESCO Finland
Subtotal parathyroidectomy
66.1
28.1
32
5
ZXE00
NOMESCO Finland
One hour or less
2.2
28.0
424
2555
WW500
NOMESCO Finland
Blood transfusion
6.0
27.6
79
142
ZST00
NOMESCO Finland
Procedure related to previous procedure classified in chapter T
48.7
27.6
33
7
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
48.7
27.6
33
7
ZXA05
NOMESCO Finland
Left side
2.5
27.6
257
1218
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
5.0
27.3
91
196
KAS20
NOMESCO Finland
Allogenic transplantation of kidney from living donor
55.1
27.3
32
6
N05.9
ICD-10 Finland
Unspecified nephritic syndrome, unspecified
64.0
27.1
31
5
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
4.2
27.1
109
285
TK824
NOMESCO Finland
Replacement of peritoneal dialysis catheter extension tube
99.7
26.8
29
*
RS220
NOMESCO Finland
NA
10.0
26.8
54
57
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.3
26.4
297
1548
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.6
25.7
228
1044
D89.8
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
+∞
25.1
24
*
C07AB02
ATC
metoprolol; systemic
2.7
25.1
200
863
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
3.2
25.0
145
510
WX203
NOMESCO Finland
Infraclavicular plexus blockade
8.0
24.9
57
75
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
11.5
24.6
46
42
R4190
NOMESCO Finland
Nutritional therapy
4.8
24.5
85
191
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
7.1
24.0
60
90
C02EA02
ATC
NA
5.8
23.9
69
126
B01AB10
ATC
tinzaparin; parenteral
4.2
23.7
93
237
XF400
NOMESCO Finland
ECG with 12 standard connections
2.6
23.2
194
854
PG5DE
NOMESCO Finland
Ultrasound examination of injection gate to artery or vein with Doppler method
37.3
23.1
29
8
WX002
NOMESCO Finland
Sedation and analgesia
2.5
22.8
209
969
N25.0
ICD-10 Finland
Renal osteodystrophy
85.6
22.8
25
*
PG1XE
NOMESCO Finland
Other ultrasound examination of blood vessel not elsewhere classified
19.5
22.7
34
18
ZXD10
NOMESCO Finland
Scheduled procedure
2.1
22.7
384
2368
PBM10
NOMESCO Finland
Closure of arteriovenous fistula of radial artery
28.1
22.4
30
11
M10.3
ICD-10 Finland
Gout due to impairment of renal function
36.0
22.1
28
8
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
4.2
21.9
86
219
WW409
NOMESCO Finland
Other aferesis
82.1
21.8
24
*
XPX08
NOMESCO Finland
Intraoperative flow measurement
18.0
21.4
33
19
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
7.7
21.4
50
68
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
4.8
21.4
74
166
C07AB07
ATC
bisoprolol; oral
2.0
21.3
406
2604
212
Kela drug reimbursment
Gout
9.0
21.3
45
52
A41.9
ICD-10 Finland
Sepsis, unspecified
5.4
21.3
65
127
PBL09
NOMESCO Finland
Construction of arteriovenous fistula from brachial artery
51.3
21.2
25
5
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
3.6
20.9
101
308
N08.2*D59.3
ICD-10 Finland
Glomerular disorders in haemolytic-uraemic syndrome
+∞
20.9
20
*
PG5AC
NOMESCO Finland
Contrast examination of injection gate to artery or vein
+∞
20.9
20
*
L04AA05
ATC
[U] tacrolimus; systemic
78.6
20.8
23
*
T86.1
ICD-10 Finland
Kidney transplant failure and rejection
78.6
20.8
23
*
7151
FHL
Kidney transplantation
49.2
20.2
24
5
N00.9
ICD-10 Finland
Acute nephritic syndrome, Unspecified
58.8
20.0
23
*
H02AB09
ATC
hydrocortisone; systemic
6.4
20.0
53
87
7910X
ICD-9 Finland
Nonspecific findings on examination of urine, Proteinuria[PROTEINURIA NUD]
75.1
19.8
22
*
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
29.7
19.7
26
9
A02BC01
ATC
omeprazole; systemic
2.1
19.7
268
1489
KBV00
NOMESCO Finland
Insertion of stent into ureter
12.5
19.7
35
29
N04.9
ICD-10 Finland
Nephrotic syndrome, unspecified
18.2
19.6
30
17
N03.0
ICD-10 Finland
Chronic nephritic syndrome, minor glomerular abnormality
107.3
19.6
21
*
V03AE04
ATC
calcium acetate and magnesium carbonate; systemic
107.3
19.6
21
*
L95.9
ICD-10 Finland
Vasculitis limited to skin, unspecified
25.2
19.6
27
11
C10AA01
ATC
simvastatin; oral
2.0
19.5
359
2246
M10.0
ICD-10 Finland
Idiopathic gout
5.8
19.5
56
102
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
26.7
19.2
26
10
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.0
19.2
335
2053
A02BC02
ATC
pantoprazole; systemic
1.9
19.2
563
4167
ZX108
NOMESCO Finland
Inhalation
16.3
18.9
30
19
N082, D899
ICD-10 Finland
NA
+∞
18.8
18
*
58399
ICD-8 Finland
Nephritis, unqualified
39.3
18.6
23
6
A10BH05
ATC
linagliptin; oral
4.7
18.5
64
144
UKC02
NOMESCO Finland
Cystoscopy
2.4
18.3
172
798
N02.9
ICD-10 Finland
Recurrent and persistent haematuria, unspecified
44.9
18.3
22
5
J01FF01
ATC
clindamycin; systemic
2.0
18.1
270
1548
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.8
17.9
122
472
I12.0
ICD-10 Finland
Hypertensive renal disease with renal failure
16.0
17.6
28
18
3025
Kela drug reimbursment
Calcium carbonate
29.4
17.5
23
8
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.1
17.5
99
340
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
5.9
17.4
49
87
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
3.6
17.4
82
245
WX610
NOMESCO Finland
Patient controlled analgesia
19.1
17.4
26
14
N28.9
ICD-10 Finland
Disorder of kidney and ureter, unspecified
24.6
17.4
24
10
N02AX02
ATC
tramadol; systemic, rectal
1.9
17.1
387
2579
C08CA03
ATC
isradipine; systemic
11.8
17.1
31
27
J01MA02
ATC
ciprofloxacin; systemic
1.9
17.1
356
2306
I15.0
ICD-10 Finland
Renovascular hypertension
19.7
16.9
25
13
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.1
16.8
220
1189
N08.2*D89.1
ICD-10 Finland
Glomerular disorders in cryoglobulinaemia
+∞
16.7
16
*
A46
ICD-10 Finland
Erysipelas
2.5
16.7
143
633
J01CA04
ATC
amoxicillin; systemic
2.0
16.5
757
6364
5997A
ICD-9 Finland
Other disorders of urethra and urinary tract, Haematuria
23.5
16.5
23
10
J01MA12
ATC
levofloxacin; systemic
2.2
16.3
180
904
J01DB01
ATC
cefalexin; oral
2.0
16.2
762
6433
6BA02
NOMESCO Finland
NA
30.6
16.2
21
7
H15.1
ICD-10 Finland
Episcleritis
8.2
15.9
35
44
JAL10
NOMESCO Finland
Laparotomy and removal of foreign body
61.1
15.8
18
*
WX892
NOMESCO Finland
Monitored bed care
2.9
15.6
98
359
C10AA04
ATC
fluvastatin; oral
3.1
15.6
90
313
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
3.2
15.6
87
294
5839X
ICD-9 Finland
Nephritis and nephropathy, not specified as acute or chronic, With unspecified pathological lesion in kidney
162.6
15.5
16
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.6
15.5
72
213
N02BE01
ATC
paracetamol; systemic, rectal
2.0
15.4
762
6465
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.9
15.4
96
349
WX402
NOMESCO Finland
General anaesthesia
2.1
15.3
187
976
C02DE10
ATC
NA
16.4
15.3
24
15
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
29.1
15.2
20
7
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.1
15.2
205
1119
ZX121
NOMESCO Finland
Central venous catheter
20.4
15.1
22
11
N06.9
ICD-10 Finland
Isolated proteinuria with specified morphological lesion, unspecified
45.8
15.1
18
*
J01MA14
ATC
moxifloxacin; systemic
2.8
15.1
104
406
UJF32
NOMESCO Finland
Coloscopy
2.0
15.1
227
1294
GD1AD
NOMESCO Finland
Thorax CT examination
4.0
14.8
60
158
58200
ICD-8 Finland
Chronic nephritis, Cum uraemia
57.6
14.8
17
*
N02.8
ICD-10 Finland
Recurrent and persistent haematuria, other
+∞
14.6
14
*
SAA03
NOMESCO Finland
Extended examination of mouth
1.8
14.5
375
2569
K65.8
ICD-10 Finland
Other peritonitis
36.6
14.5
18
5
H05BX02
ATC
paricalcitol; systemic
36.6
14.5
18
5
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
3.4
14.5
71
220
RS221
NOMESCO Finland
NA
6.8
14.4
36
55
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
5.5
14.4
42
79
C08CA05
ATC
nifedipine; systemic
3.4
14.3
72
227
K06.18
ICD-10 Finland
Another gingival hyperplasia
19.5
14.3
21
11
WX110
NOMESCO Finland
Local anesthesy
1.8
14.3
642
5189
Z3229
NOMESCO Finland
Other healthcare associate professional
2.7
14.0
97
378
E87.5
ICD-10 Finland
Hyperkalaemia
9.0
14.0
29
33
WX202
NOMESCO Finland
Supraclavicular plexus blockade
7.2
13.9
33
47
RS222
NOMESCO Finland
NA
8.3
13.9
30
37
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
3.4
13.8
69
217
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
9.3
13.8
28
31
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
4.3
13.8
51
124
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.2
13.7
52
129
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.8
13.7
91
346
M08.2
ICD-10 Finland
Juvenile arthritis with systemic onset
76.3
13.6
15
*
120
Kela drug reimbursment
Hypogammaglobulinaemia
+∞
13.6
13
*
187
Kela drug reimbursment
MPA
+∞
13.6
13
*
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.0
13.4
196
1099
M01AB05
ATC
diclofenac; systemic, rectal
0.6
13.3
348
4683
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.1
13.3
173
925
306
Kela drug reimbursment
Erythropoietin and darbepoetin
40.7
13.2
16
*
JN3AD
NOMESCO Finland
Abdominal CT examination
2.8
13.0
88
340
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.8
12.9
84
316
78900
ICD-8 Finland
Abnormal urinary constituents of unspecified cause, Albuminuria
22.9
12.9
18
8
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.5
12.9
109
477
N04.1
ICD-10 Finland
Nephrotic syndrome, focal and segmental glomerular lesions
50.7
12.9
15
*
U88
ICPC
Glomerulonephritis/nephrosis
50.7
12.9
15
*
E0000UV
ATC
NA
1.7
12.8
350
2415
78930
ICD-8 Finland
Abnormal urinary constituents of unspecified cause, Haematuria
14.3
12.8
21
15
ZX131
NOMESCO Finland
Intrathecal
70.8
12.6
14
*
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
3.6
12.6
57
166
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
9.5
12.5
25
27
5820A
ICD-9 Finland
Chronic glomerulonephritis, With lesion of proliferative glomerulonephritis[GLOMERULONEPHRITIS CHRONICA PROLIF,EI NEFR SDR]
+∞
12.5
12
*
4059B
ICD-9 Finland
Secondary hypertension, Unspecified[HYPERTONIA SECUNDARIA ALIA DEFINITA]
131.7
12.5
13
*
TKA00
NOMESCO Finland
Needle biopsy of kidney or pelvis of kidney
131.7
12.5
13
*
6112
FHL
Installation of a peritoneal dialysis or lavage catheter in an operating room
131.7
12.5
13
*
C09AA05
ATC
ramipril; oral
1.9
12.4
209
1232
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
3.6
12.4
55
158
M10
ICD-10 Finland
Gout
3.6
12.4
55
158
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
11.8
12.4
22
19
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.3
12.3
63
202
D64.9
ICD-10 Finland
Anaemia, unspecified
2.5
12.3
99
420
B01AA03
ATC
warfarin; systemic
2.1
12.3
160
853
WX204
NOMESCO Finland
Axillary plexus blockaced
4.4
12.3
44
104
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.8
12.3
79
295
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.0
12.2
72
256
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.6
12.1
55
161
Z99.2
ICD-10 Finland
Dependence on renal dialysis
27.1
12.1
16
6
I15.9
ICD-10 Finland
Secondary hypertension, unspecified
10.2
12.0
23
23
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
4.5
12.0
42
97
B01AB04
ATC
dalteparin; parenteral
3.6
12.0
53
152
J05AB11
ATC
valaciclovir; oral
2.3
12.0
118
557
M01AH05
ATC
etoricoxib; oral
0.6
11.9
280
3905
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
11.9
11.9
21
18
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
11.8
197
1153
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
4.7
11.8
39
85
KAS96
NOMESCO Finland
Other transplantation of kidney or related procedure
65.8
11.6
13
*
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.8
11.6
75
281
M13.9
ICD-10 Finland
Arthritis, unspecified
2.8
11.6
75
281
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.7
11.5
82
324
N18.3
ICD-10 Finland
Chronic kidney disease, stage 3
121.4
11.4
12
*
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
7.4
11.3
26
36
PBU84
NOMESCO Finland
Plastic repair of arteriovenous fistula from artery of upper extremity
35.5
11.3
14
*
WW400
NOMESCO Finland
Plasmaferesis
25.4
11.2
15
6
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.2
11.1
122
605
SBB20
NOMESCO Finland
Tooth X-ray examination in conjunction with visit to dentist
8.2
11.1
24
30
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
11.3
11.1
20
18
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
5.8
10.9
30
53
N08.5*M31.3
ICD-10 Finland
Glomerular disorders in Wegener's granulomatosis
43.8
10.9
13
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.0
10.9
154
846
C09BA02
ATC
enalapril and diuretics; systemic
2.7
10.9
78
310
Q61.2
ICD-10 Finland
Polycystic kidney, autosomal dominant
12.1
10.9
19
16
L01BB01
ATC
NA
28.4
10.7
14
5
KAC11
NOMESCO Finland
Total nephrectomy with capsule, transcutaneous
28.4
10.7
14
5
L01BB02
ATC
mercaptopurine; oral
7.7
10.7
24
32
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
6.1
10.6
28
47
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.7
10.6
250
1633
B02.9
ICD-10 Finland
Zoster without complication
3.1
10.6
57
190
SPAT1262
SPAT
Handing over of treatment supplies
1.9
10.6
164
929
N17.8
ICD-10 Finland
Other acute renal failure
8.6
10.6
22
26
B01AC04
ATC
clopidogrel; oral
2.0
10.5
132
694
40399
ICD-8 Finland
Hypertensive renal disease
111.2
10.4
11
*
5828B
ICD-9 Finland
Chronic glomerulonephritis, With other specified pathological lesion in kidney[GLOMERULONEPHRITIS CHRONICA ALIA DEF,NEFR SDR]
111.2
10.4
11
*
A12BA01
ATC
potassium chloride; oral
4.2
10.4
39
97
E83.51
ICD-10 Finland
Hypocalcemia
16.2
10.4
16
10
KBV10
NOMESCO Finland
Removal of stent from ureter
8.3
10.4
22
27
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.5
10.3
84
360
C03AA03
ATC
hydrochlorothiazide; oral
2.5
10.2
79
331
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.8
10.0
63
233
XF402
NOMESCO Finland
ECG with work load test
2.2
10.0
105
508
5829A
ICD-9 Finland
Chronic glomerulonephritis with unspecified pathological lesion in kidney[GLOMERULONEPHRITIS CHRONICA NUD ,EI NEFR SDR]
40.5
10.0
12
*
E21.2
ICD-10 Finland
Other hyperparathyroidism
40.5
10.0
12
*
TJW99
NOMESCO Finland
Other minor procedure in gastrointestinal endoscopy
40.5
10.0
12
*
ZX112
NOMESCO Finland
Subcutaneous
5.0
10.0
31
64
B07.9
ICD-10 Finland
Verruca simplex
3.5
9.9
46
138
L01AA01
ATC
cyclophosphamide; systemic
16.9
9.9
15
9
5AB14
NOMESCO Finland
NA
16.9
9.9
15
9
N17.0
ICD-10 Finland
Acute renal failure with tubular necrosis
12.3
9.9
17
14
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
20.3
9.8
14
7
C09CA07
ATC
telmisartan; oral
2.6
9.8
69
273
H02AB07
ATC
prednisone; oral
2.0
9.7
122
641
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
3.3
9.7
48
152
2AX04
NOMESCO Finland
NA
55.6
9.7
11
*
N18.4
ICD-10 Finland
Chronic kidney disease, stage 4
55.6
9.7
11
*
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.5
9.5
75
317
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.8
9.5
61
230
Z85.6
ICD-10 Finland
Personal history of leukaemia
101.0
9.4
10
*
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
17.7
9.4
14
8
XF612
NOMESCO Finland
Measurement of central venous pressure
30.3
9.4
12
*
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.9
9.4
156
905
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
+∞
9.4
9
*
D86.0
ICD-10 Finland
Sarcoidosis of lung
+∞
9.4
9
*
YNB20
NOMESCO Finland
Storage of stem cells for transplant
+∞
9.4
9
*
D86.8
ICD-10 Finland
Sarcoidosis of other and combined sites
+∞
9.4
9
*
B05D
ATC
PERITONEAL DIALYTICS
+∞
9.4
9
*
N08.2*D65
ICD-10 Finland
Glomerular disorders in disseminated intravascular coagulation [defibrination syndrome]
+∞
9.4
9
*
N082, D8989
ICD-10 Finland
NA
+∞
9.4
9
*
D89.0
ICD-10 Finland
Polyclonal hypergammaglobulinaemia
+∞
9.4
9
*
A06AD11
ATC
lactulose; oral
2.1
9.3
105
526
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
4.4
9.3
32
74
J01CF05
ATC
flucloxacillin; systemic
3.2
9.2
46
147
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.9
9.2
149
858
ECA35
NOMESCO Finland
Complicated excision of lesion of gingiva
37.1
9.0
11
*
XG410
NOMESCO Finland
Flow-volume spirometry
3.0
8.9
49
167
K65.9
ICD-10 Finland
Peritonitis, unspecified
18.8
8.9
13
7
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
5.6
8.9
25
46
TAB00
NOMESCO Finland
Lumbar puncture
2.9
8.9
53
191
A41.8
ICD-10 Finland
Other specified sepsis
5.4
8.8
25
47
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
3.1
8.8
46
152
R06.0
ICD-10 Finland
Dyspnoea
1.7
8.7
192
1219
T92
ICPC
Gout
4.9
8.7
27
56
UJF30
NOMESCO Finland
Ileoscopy through colon
2.3
8.7
82
377
WZC30
NOMESCO Finland
Teaching
1.9
8.7
124
681
BBA50
NOMESCO Finland
Total parathyroidectomy
50.5
8.7
10
*
SPAT1255
SPAT
Intravenous administration of medicine
2.6
8.6
63
256
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
4.1
8.6
32
80
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.8
8.6
55
207
M31.3
ICD-10 Finland
Wegener granulomatosis
16.5
8.6
13
8
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
9.1
8.6
17
19
B99
ICD-10 Finland
Other and unspecified infectious diseases
5.0
8.5
26
53
TPH07
NOMESCO Finland
Cathetrisation of artery
2.1
8.5
97
487
I50.9
ICD-10 Finland
Heart failure, unspecified
2.2
8.5
88
423
ZX197
NOMESCO Finland
NA
27.8
8.5
11
*
E21.1
ICD-10 Finland
Secondary hyperparathyroidism, not elsewhere classified
27.8
8.5
11
*
M04AA03
ATC
febuxostat; oral
20.2
8.5
12
6
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.9
8.5
124
687
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.2
8.5
86
413
C08DB01
ATC
diltiazem; oral
3.1
8.5
44
145
R60.0
ICD-10 Finland
Localized oedema
2.2
8.5
85
403
TK823
NOMESCO Finland
Peritoneal permeability analysis
90.8
8.4
9
*
RS321
NOMESCO Finland
NA
90.8
8.4
9
*
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
90.8
8.4
9
*
TQW80
NOMESCO Finland
Local dermatologic skincare
4.1
8.4
31
77
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
12.9
8.4
14
11
WX882
NOMESCO Finland
High dependency care
3.2
8.4
42
135
JN4AD
NOMESCO Finland
Body CT examination
2.4
8.4
69
297
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
1.7
8.4
209
1377
1XX02
NOMESCO Finland
NA
+∞
8.3
8
*
I12.9
ICD-10 Finland
Hypertensive renal disease without renal failure
+∞
8.3
8
*
N082, Z940
ICD-10 Finland
NA
+∞
8.3
8
*
KAS40
NOMESCO Finland
Excision of transplanted kidney
+∞
8.3
8
*
N082, D890
ICD-10 Finland
NA
+∞
8.3
8
*
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
+∞
8.3
8
*
SAA04
NOMESCO Finland
Special inverstigation of mouth
2.4
8.3
67
287
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.5
8.3
389
2991
PB1DE
NOMESCO Finland
Upper extremity arteries ultrasound examination with Doppler method
10.9
8.3
15
14
K00.40
ICD-10 Finland
Postnatal enamel hypoplasia
7.6
8.2
18
24
ZX114
NOMESCO Finland
Intramuscular
5.7
8.2
22
39
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.0
8.1
107
572
TDM10
NOMESCO Finland
Puncture of maxillary antrum
3.1
8.1
42
138
UJF92
NOMESCO Finland
Capsular endoscopy
4.0
8.1
31
80
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.7
8.1
168
1049
N08.5
ICD-10 Finland
Glomerular disorders in systemic connective tissue disorders
33.6
8.1
10
*
TK830
NOMESCO Finland
Ultrafiltration
33.6
8.1
10
*
288
Kela drug reimbursment
Febuxostat
17.3
8.1
12
7
L57.0
ICD-10 Finland
Actinic keratosis
2.4
8.1
70
309
C10AX09
ATC
ezetimibe; oral
2.1
8.1
92
464
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
3.3
8.0
38
117
Z94.9
ICD-10 Finland
Transplanted organ and tissue status, unspecified
22.2
8.0
11
5
L95.8
ICD-10 Finland
Other vasculitis limited to skin
22.2
8.0
11
5
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
3.4
8.0
37
112
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
4.5
8.0
27
62
XF600
NOMESCO Finland
Bloodpressure measurement
2.4
8.0
68
301
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
4.8
8.0
25
53
GD1LA
NOMESCO Finland
GD
5.0
7.9
24
49
KH1EE
NOMESCO Finland
Urologic ultrasound examination
13.2
7.9
13
10
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
3.1
7.9
41
136
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
5.8
7.9
21
37
ZY010
NOMESCO Finland
Hospital outpatient
2.5
7.8
58
239
EB1WA
NOMESCO Finland
NA
9.5
7.8
15
16
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
6.4
7.7
19
30
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.3
7.7
66
293
RJ420
NOMESCO Finland
NA
18.5
7.6
11
6
H35.0
ICD-10 Finland
Background retinopathy and retinal vascular changes
12.0
7.6
13
11
TPX15
NOMESCO Finland
Removal of vascular injection port
12.0
7.6
13
11
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
5.2
7.6
22
43
9835/3-C42.1
ICD-O-3
Precursor cell lymphoblastic leukemia, NOS, of bone marrow
25.2
7.6
10
*
N11.9
ICD-10 Finland
Chronic tubulo-interstitial nephritis, unspecified
25.2
7.6
10
*
J02AC03
ATC
voriconazole; systemic
25.2
7.6
10
*
ED1AA
NOMESCO Finland
Mandipular X-ray examination
8.9
7.6
15
17
ZXA10
NOMESCO Finland
Bilateral
1.7
7.5
149
915
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.3
7.5
65
291
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
4.9
7.5
23
48
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
7.7
7.4
16
21
EE1AA
NOMESCO Finland
X-ray of upper jaw or palate
11.0
7.3
13
12
D638, N180
ICD-10 Finland
NA
+∞
7.3
7
*
D86.1
ICD-10 Finland
Sarcoidosis of lymph nodes
+∞
7.3
7
*
N04.3
ICD-10 Finland
Nephrotic syndrome, diffuse mesangial proliferative glomerulonephritis
+∞
7.3
7
*
D86.9
ICD-10 Finland
Sarcoidosis, unspecified
+∞
7.3
7
*
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
+∞
7.3
7
*
5829B
ICD-9 Finland
Chronic glomerulonephritis with unspecified pathological lesion in kidney[GLOMERULONEPHRITIS CHRONICA NUD ,NEFR SDR]
+∞
7.3
7
*
J02AC04
ATC
posaconazole; systemic
+∞
7.3
7
*
D84.9
ICD-10 Finland
Immunodeficiency, unspecified
+∞
7.3
7
*
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
6.3
7.3
18
29
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
2.5
7.2
56
234
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
4.0
7.2
27
69
A10BH02
ATC
vildagliptin; oral
4.9
7.2
22
46
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.8
7.1
43
158
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
6.1
7.1
18
30
SDA02
NOMESCO Finland
Parodonthologic therapy
1.5
7.1
276
2022
E66.01
ICD-10 Finland
Obesity due to excess calories
2.2
7.1
71
338
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
2.1
7.1
80
401
J01DA01
ATC
[U] cefalexin; systemic
1.4
7.0
519
4330
C07AG01
ATC
labetalol; systemic
5.9
6.9
18
31
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
7.6
6.9
15
20
NA3SA
NOMESCO Finland
Lumbar spine X-ray examination in standing position
7.6
6.9
15
20
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.9
6.9
97
531
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
2.2
6.9
72
349
I50.0
ICD-10 Finland
Congestive heart failure
2.5
6.8
49
199
H01AC01
ATC
somatropin; parenteral
8.3
6.8
14
17
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
11.0
6.8
12
11
PG1AE
NOMESCO Finland
Ultrasound examination of artery not elsewher classified
9.4
6.8
13
14
FM2CE
NOMESCO Finland
NA
5.4
6.8
19
36
N04.89
ICD-10 Finland
Nephrotic syndrome, other
40.3
6.8
8
*
N03.1
ICD-10 Finland
Chronic nephritic syndrome, focal and segmental glomerular lesions
40.3
6.8
8
*
PG9AC
NOMESCO Finland
Arteriography with X-ray not elsewhere classified
16.8
6.8
10
6
A02BA02
ATC
ranitidine; systemic
1.7
6.7
146
921
K05.30
ICD-10 Finland
Periodontitis complex
1.8
6.7
105
600
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
3.1
6.7
34
112
R04.0
ICD-10 Finland
Epistaxis
2.3
6.7
61
279
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
2.0
6.6
79
404
N18
ICD-10 Finland
Chronic kidney disease
7.9
6.6
14
18
H26.3
ICD-10 Finland
Drug-induced cataract
7.9
6.6
14
18
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.1
6.6
77
392
58099
ICD-8 Finland
Acute nephritis
12.3
6.6
11
9
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
3.4
6.6
29
86
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
4.4
6.6
22
51
Z01.2
ICD-10 Finland
Dental examination
1.5
6.6
351
2738
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
3.3
6.5
31
97
602
Kela drug reimbursment
Children's severe malnutrition
10.1
6.5
12
12
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
3.5
6.5
28
81
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
6.5
371
2928
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.1
6.5
68
333
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.5
6.5
303
2301
5850B
ICD-9 Finland
Chronic renal failure[INSUFFICIENTIA RENIS CHRONICA CUM URAEMIA]
70.3
6.4
7
*
PBM09
NOMESCO Finland
Closure of arteriovenous fistula of brachial artery
70.3
6.4
7
*
5809A
ICD-9 Finland
Acute glomerulonephritis with unspecified pathological lesion in kidney[GLOMERULONEPHRITIS ACUTA NUD,EI NEFR SDR]
70.3
6.4
7
*
4019X
ICD-9 Finland
Essential hypertension, Unspecified
3.7
6.4
26
72
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
2.8
6.4
39
145
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
3.0
6.3
33
111
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
4.6
6.3
20
44
K05.11
ICD-10 Finland
Gingivitis (chronic) hyperplastic
11.1
6.3
11
10
RJ411
NOMESCO Finland
NA
11.1
6.3
11
10
FM1LE
NOMESCO Finland
Combined ultrasound and EKG examination of heart with tolerance test
9.3
6.3
12
13
O12.1
ICD-10 Finland
Gestational proteinuria
9.3
6.3
12
13
C10AA03
ATC
pravastatin; oral
2.3
6.3
56
253
WX702
NOMESCO Finland
Supraglottic ventilation device
2.4
6.3
48
202
8260/3-C64.9
ICD-O-3
Papillary adenocarcinoma, NOS, of kidney, NOS
18.1
6.3
9
5
A05AA02
ATC
ursodeoxycholic acid; oral
4.4
6.3
21
49
C02DB01
ATC
dihydralazine; systemic
+∞
6.3
6
*
9811/3-C42.1
ICD-O-3
B lymphoblastic leukemia/lymphoma, NOS, of bone marrow
+∞
6.3
6
*
7101
FHL
Needle biopsy in the operating room
+∞
6.3
6
*
4039A
ICD-9 Finland
Hypertensive renal disease, Unspecified
+∞
6.3
6
*
N03.5
ICD-10 Finland
Chronic nephritic syndrome, diffuse mesangiocapillary glomerulonephritis
+∞
6.3
6
*
2798X
ICD-9 Finland
Disorders involving the immune mechanism, Other specified disorders involving the immune mechanism[MORBUS IMMUNOSYSTEMATIS ALIA DEFINITA]
+∞
6.3
6
*
D59.3
ICD-10 Finland
Haemolytic-uraemic syndrome
+∞
6.3
6
*
N0839, D8980
ICD-10 Finland
NA
+∞
6.3
6
*
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
+∞
6.3
6
*
M35.8
ICD-10 Finland
Other specified systemic involvement of connective tissue
26.9
6.2
8
*
PB1AC
NOMESCO Finland
Angiography of upper extremity with X-ray
26.9
6.2
8
*
N43.3
ICD-10 Finland
Hydrocele, unspecified
3.7
6.2
25
69
103
Kela drug reimbursment
Diabetes, insulin-treated
1.5
6.2
205
1441
SCD01
NOMESCO Finland
Simple removal of tooth plaque or tartar
6.3
6.2
15
24
E66.8
ICD-10 Finland
Other obesity
2.4
6.1
47
199
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.3
6.1
53
239
I11.9
ICD-10 Finland
Hypertensive heart disease without (congestive) heart failure
2.9
6.1
35
124
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.5
6.0
270
2024
Z94.4
ICD-10 Finland
Liver transplant status
10.1
6.0
11
11
WX720
NOMESCO Finland
Own respiration
2.7
6.0
37
139
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3026250) Tacrolimus [Mass/volume] in Blood
197
55
43.82
322.83
34.0
36.1
ug/l
6.9
7.4
0.83
185
49
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
282
202
18.69
321.23
10.2
7.1
iu/ml
3149.3
389.3
0.70
69
30
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
375
311
18.16
307.65
10.9
7.3
mg/l
1.8
1.4
6.94
365
294
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
573
555
21.43
307.65
11.5
5.0
ng/l
150.3
83.0
18.97
538
500
(3020779) Urea [Moles/volume] in Serum or Plasma
653
779
20.40
307.65
22.2
9.1
mmol/l
13.0
8.9
26.37
641
741
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
259
152
22.26
307.65
5.6
4.4
u/ml
163.9
3151.1
—
7
13
(40768446) Kidney Pathology biopsy report
262
42
82.69
307.65
1.7
2.0
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
734
1155
18.64
307.65
23.4
7.1
mmol/l
1.1
1.1
5.85
718
1085
(3012516) Albumin [Mass/volume] in Urine
750
2285
8.91
264.67
9.8
3.3
mg/l
609.7
270.4
1.34
696
1531
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
515
1079
8.38
262.69
8.7
2.7
%
25.1
24.2
0.67
463
924
(3042733) HLA Ab [Presence] in Serum
154
40
44.92
255.89
6.5
4.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
761
2411
8.76
255.82
11.9
4.0
mg/mmol
41.0
16.9
2.82
708
1592
(3004789) Transferrin [Mass/volume] in Serum or Plasma
524
1153
8.05
253.81
8.4
2.6
g/l
2.0
2.3
29.31
511
1074
(3009508) Creatinine [Moles/volume] in Urine
774
2600
8.44
240.93
9.7
3.4
mmol/l
7.0
8.4
16.35
748
2198
(3010375) cycloSPORINE [Mass/volume] in Blood
152
48
36.83
239.22
27.2
36.6
ug/l
96.3
141.6
3.54
128
43
(3022948) Iron [Moles/volume] in Serum or Plasma
527
1242
7.49
235.99
8.4
2.6
umol/l
12.6
13.9
4.25
515
1155
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
240
218
13.96
235.45
2.7
1.5
u/ml
110.2
124.2
0.28
62
38
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
240
228
13.34
228.55
2.7
1.5
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
808
2934
8.51
228.03
11.3
3.3
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
239
232
13.03
224.26
2.6
1.5
u/ml
23.0
13.2
—
7
5
(3000850) Epithelial cells [#/volume] in Urine
599
1682
6.93
220.99
7.2
2.6
e6/l
2.7
4.7
7.84
568
1482
(3009445) Proteinase 3 Ab [Units/volume] in Serum
281
350
10.58
220.86
1.9
1.4
u/ml
42.6
9.3
—
10
11
(3024561) Albumin [Mass/volume] in Serum or Plasma
840
3304
8.60
212.91
17.4
5.5
g/l
34.7
36.0
11.84
820
3110
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
119
24
55.77
208.65
5.3
6.9
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
708
2459
6.72
202.54
9.7
3.3
e6/l
63.8
83.7
0.31
636
1902
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
224
236
11.78
197.91
1.8
1.4
u/ml
243.6
242.5
0.01
174
135
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
223
246
11.23
190.45
1.7
1.4
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
650
2186
6.15
189.73
6.2
2.8
umol/l
891.3
6042.4
4.95
625
1937
(36304419) Bacteria [Presence] in Urine
653
2209
6.14
189.18
8.9
3.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
659
2258
6.12
187.75
9.3
3.2
e6/l
0.2
0.4
5.12
568
1710
(3018418) pH of Serum or Plasma
652
2214
6.10
187.70
21.4
4.2
ph
7.4
7.4
6.19
134
440
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
257
348
9.44
187.61
2.7
2.1
g/l
1.4
1.4
0.21
229
303
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
161
110
17.09
184.81
1.1
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
163
116
16.44
183.04
2.2
2.5
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
294
485
8.02
180.86
19.9
5.9
mmol/l
23.0
24.0
6.01
281
453
(3018095) Leukocytes [#/volume] in Urine
740
2871
6.30
180.26
11.9
3.7
e6/l
22.5
76.9
2.36
653
2043
(3002032) Base excess in Venous blood by calculation
375
816
6.58
175.81
18.9
5.3
mmol/l
0.2
1.8
12.39
325
651
(3021447) Carbon dioxide [Partial pressure] in Venous blood
375
822
6.53
174.33
18.8
5.2
kpa
5.8
5.8
0.28
370
803
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
216
263
10.07
170.73
1.9
1.5
g/l
0.3
0.2
2.32
201
251
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
845
3825
7.10
167.69
34.6
7.7
mmol/l
1.2
1.2
2.65
755
3262
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
218
275
9.73
167.52
1.9
1.5
g/l
1.2
1.2
0.02
205
262
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
801
3499
6.37
164.48
28.7
7.2
mmol/l
1.2
1.2
6.92
778
3211
(3026782) Osmolality of Urine
520
1598
5.45
163.79
7.8
2.7
mosm/kgh2o
503.9
574.4
13.51
487
1367
(3018677) aPTT in Platelet poor plasma by Coagulation assay
454
1260
5.57
160.94
4.3
2.6
s
29.4
29.8
0.92
446
1228
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
100
31
35.53
157.17
1.1
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
241
374
8.06
155.25
1.7
1.4
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
748
3188
5.64
154.99
4.3
2.4
nmol/l
74.3
74.1
0.08
735
2892
(3024932) HLA-DR beta [Type]
106
42
27.95
153.88
1.1
1.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
100
34
32.39
152.77
1.1
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
106
43
27.30
152.57
1.0
1.0
—
—
—
0
0
(3000991) Gas panel - Venous blood
335
762
5.98
147.33
19.1
10.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
457
1368
5.13
145.80
6.1
2.8
e6/l
0.5
1.0
2.69
302
784
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
130
92
15.98
145.71
1.5
1.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
153
145
12.17
143.83
9.1
3.2
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
77
13
63.82
138.83
12.5
4.3
mmol/l
5.5
7.1
1.18
77
13
(3020630) Protein [Mass/volume] in Serum or Plasma
287
599
6.21
137.70
3.4
2.8
g/l
64.8
67.1
4.32
274
548
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
351
885
5.45
136.43
6.0
4.6
u/l
239.0
246.4
0.45
339
840
(42870588) Differential panel, method unspecified - Blood
682
2901
4.83
135.83
14.3
6.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
397
1129
5.04
133.24
3.9
1.6
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
114
75
16.92
132.60
1.2
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
282
622
5.82
126.71
4.2
2.5
ml/min/173m2
42.6
70.4
18.66
136
242
(3012095) Magnesium [Moles/volume] in Serum or Plasma
427
1333
4.70
126.48
6.7
4.2
mmol/l
0.8
0.8
1.57
412
1261
(3024928) Oxygen saturation in Venous blood
153
174
10.12
126.11
14.7
5.9
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
298
699
5.55
124.86
15.2
4.6
kpa
6.4
4.8
9.89
291
683
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
187
278
7.96
123.92
1.8
1.6
titre
172.9
217.1
—
7
7
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
414
1300
4.60
120.92
6.8
3.1
e6/l
1.3
1.5
0.20
256
720
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
95
52
19.98
120.65
5.9
1.9
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
83
33
27.22
119.93
3.1
2.6
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
175
262
7.81
114.95
4.2
4.0
u/ml
0.3
0.4
1.41
78
142
(3027945) Reticulocytes/100 erythrocytes in Blood
327
888
4.89
114.21
7.0
3.4
%
1.9
1.8
1.13
312
810
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
93
55
18.45
113.82
5.9
2.1
%
12.1
11.5
0.11
72
31
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
423
1419
4.31
111.76
3.7
1.6
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
275
658
5.30
111.64
5.5
3.3
e9/l
69.3
72.0
0.49
202
505
(3014148) Varicella zoster virus Ab [Titer] in Serum
121
121
11.17
109.03
1.2
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
99
73
14.86
107.91
15.7
8.5
%
11.3
10.6
0.69
99
73
(3004588) Protein electrophoresis panel - Serum or Plasma
226
471
5.84
106.88
2.2
2.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
765
3992
4.34
104.71
9.0
3.3
estimate
0.0
0.0
0.14
183
730
(3035350) Ketones [Presence] in Urine by Test strip
758
3960
4.26
102.82
9.0
3.2
estimate
0.0
0.0
0.00
182
750
(3021601) Nitrite [Presence] in Urine by Test strip
756
3945
4.24
102.66
12.5
4.5
estimate
0.0
0.0
0.50
189
780
(3011412) CD3 cells [#/volume] in Blood
98
80
13.40
100.56
5.7
2.1
e9/l
1.3
1.2
0.56
76
40
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
118
130
10.10
99.04
1.2
1.1
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
148
219
7.70
97.74
3.1
3.9
mg/l
68.6
84.4
0.22
113
171
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
148
219
7.70
97.74
3.1
3.9
mg/l
57.3
36.6
2.84
111
172
(21494890) Protein electrophoresis panel - 24 hour Urine
93
73
13.88
97.65
2.1
2.5
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
174
312
6.48
95.79
6.2
4.8
g/l
0.7
0.3
1.75
138
167
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
146
218
7.61
95.58
3.1
3.8
ratio
1.3
1.9
—
9
25
(3037467) Urinalysis macro (dipstick) panel - Urine
913
5616
5.68
95.13
12.7
3.9
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
174
316
6.40
94.52
2.2
1.3
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
773
4252
4.07
93.38
15.5
6.2
e9/l
0.6
0.6
4.39
711
3676
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
84
60
15.13
93.00
6.0
2.2
e9/l
0.2
0.2
0.34
66
50
(3006315) Basophils [#/volume] in Blood
773
4264
4.05
92.69
15.5
6.3
e9/l
0.0
0.0
0.29
712
3695
(3021879) Hepatitis B virus core Ab [Presence] in Serum
265
714
4.62
91.70
2.4
1.5
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
699
3635
3.74
91.18
8.4
2.8
ug/l
213.9
134.9
8.44
684
3387
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
84
63
14.40
90.46
6.0
2.2
e6/l
594.1
542.6
0.23
66
51
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
283
812
4.40
90.10
4.3
3.2
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
742
4048
3.81
88.95
16.7
6.7
%
8.8
8.7
0.62
733
3823
(3022096) Basophils/100 leukocytes in Blood
726
3907
3.76
88.88
16.5
6.4
%
0.6
0.7
1.31
719
3683
(3019198) Lymphocytes [#/volume] in Blood
779
4388
3.97
88.86
15.6
6.3
e9/l
1.8
2.1
2.08
715
3881
(3013115) Eosinophils [#/volume] in Blood
780
4406
3.96
88.39
17.1
6.7
e9/l
0.2
0.2
1.08
723
3886
(46235355) HIV 1 and 2 tests - Meaningful Use set
446
1775
3.62
88.23
3.7
1.9
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
738
4027
3.78
88.10
16.4
6.4
%
2.9
2.9
0.11
732
3784
(3011397) Hemoglobin [Presence] in Urine by Test strip
444
1788
3.56
85.78
8.1
3.3
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
748
4179
3.72
84.63
16.4
6.4
%
25.9
28.7
9.60
738
3936
(3023368) Bacteria identified in Blood by Culture
493
2142
3.45
83.96
9.0
4.5
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
738
4116
3.65
83.09
16.0
6.2
%
59.1
56.5
7.34
730
3893
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
179
376
5.53
82.91
13.8
3.9
%
0.6
0.7
0.36
179
365
(3042936) Bacteria identified in Isolate by Culture
346
1211
3.76
82.47
2.7
2.1
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
59
26
23.98
81.66
7.2
1.8
e6/l
266.1
276.0
—
28
10
(3032080) INR in Blood by Coagulation assay
621
3144
3.37
81.38
16.3
8.6
inr
1.2
1.2
0.05
189
959
(3005719) IgG [Mass/volume] in Serum or Plasma
249
698
4.36
81.07
7.0
2.2
g/l
9.6
10.6
2.74
230
640
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
107
137
8.58
79.58
1.8
1.4
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
841
5183
4.08
79.25
8.1
3.9
e6/l
39.9
261.2
1.29
14
72
(40760888) Immunoglobulin light chains.free panel - Serum
114
164
7.67
76.75
3.3
4.0
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
326
1146
3.67
76.49
1.5
1.3
titre
640.0
452.0
0.59
60
217
(3012565) Volume of 24 hour Urine
68
47
15.40
76.46
2.5
2.9
ml
1973.0
2075.8
0.23
62
42
(3013650) Neutrophils [#/volume] in Blood by Automated count
803
4860
3.74
76.43
19.6
9.5
e9/l
4.5
4.1
5.33
745
4237
(3033658) Prothrombin time (PT) actual/Normal
473
2114
3.24
75.00
10.7
4.3
%
98.1
89.9
7.94
464
2074
(3015377) Calcium [Moles/volume] in Serum or Plasma
523
2496
3.17
73.76
6.9
3.3
mmol/l
2.3
2.4
2.82
498
2233
(1616796) Gas panel - Central venous blood
118
185
7.06
73.41
8.4
3.4
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
207
552
4.42
71.39
3.1
1.7
g/l
1.1
1.3
1.37
191
512
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
923
6272
4.79
70.69
18.0
7.7
u/l
80.3
80.1
0.03
912
5932
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
117
194
6.66
68.92
1.9
1.2
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
97
131
8.05
68.84
3.3
1.9
g/l
0.9
0.9
0.09
67
102
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
222
647
4.08
67.71
7.8
4.9
kpa
5.0
5.2
3.61
213
608
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
264
870
3.71
67.42
2.5
1.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
265
876
3.71
67.36
2.6
1.9
—
—
—
0
0
(3009343) pH of Capillary blood
220
641
4.07
67.09
7.6
4.9
ph
7.4
7.4
0.63
48
73
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
215
617
4.12
66.94
7.5
5.0
mmol/l
0.5
1.6
4.08
158
450
(3016750) Collection duration of Urine
67
57
12.48
66.67
3.7
2.4
min
507.6
500.7
0.19
59
39
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
328
1252
3.35
66.43
2.6
1.9
—
—
—
0
0
(4062490)
73
73
10.67
65.27
2.8
1.3
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
234
729
3.84
64.72
15.7
9.5
mmol/l
1.1
1.4
5.03
228
702
(3028192) IgG subclass 2 [Mass/volume] in Serum
72
72
10.66
64.36
2.6
1.3
g/l
2.6
3.0
0.82
47
50
(3027135) IgG subclass 1 [Mass/volume] in Serum
72
72
10.66
64.36
2.6
1.3
g/l
6.1
7.0
1.16
47
51
(3024139) IgG subclass 3 [Mass/volume] in Serum
72
72
10.66
64.36
2.6
1.3
g/l
0.4
0.4
0.17
46
50
(3021589) Normoblasts [#/volume] in Blood
659
3802
2.96
62.58
26.3
9.7
e9/l
0.0
0.0
0.44
529
3094
(40758558) Short blood count panel - Blood
444
2078
2.96
62.43
15.0
6.7
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
127
253
5.57
61.77
1.8
2.6
g/l
10.0
10.5
0.50
109
220
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
131
275
5.30
60.06
1.9
2.6
g/l
4.5
3.9
3.36
101
204
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
131
275
5.30
60.06
1.9
2.6
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
131
275
5.30
60.06
1.9
2.6
g/l
7.3
7.2
0.34
102
215
(3004775) Volume in Urine collected for unspecified duration
68
72
10.03
58.30
3.6
2.3
ml
818.5
659.4
1.52
60
44
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
689
4181
2.87
57.50
10.1
6.8
umol/l
10.1
12.0
4.40
668
3979
(3014576) Chloride [Moles/volume] in Serum or Plasma
275
1022
3.29
57.24
15.1
8.4
mmol/l
103.4
104.4
2.47
270
1000
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
112
213
5.76
57.17
2.4
1.8
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
112
214
5.74
56.88
2.3
1.8
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
115
230
5.49
55.55
5.3
3.2
mmol/l
22.8
24.7
3.91
108
205
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
122
259
5.20
55.10
1.9
2.7
g/l
3.2
3.1
0.37
101
207
(3037756) Immunofixation for Serum or Plasma
91
148
6.64
54.38
1.4
1.6
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
187
559
3.85
54.32
2.1
1.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
83
128
6.95
52.13
2.3
1.8
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
133
323
4.57
51.00
1.9
1.2
u/l
35.8
36.8
0.21
121
288
(3007853) Bacteria identified in Skin by Aerobe culture
262
1012
3.11
50.45
2.6
1.6
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
401
1955
2.70
49.86
3.1
2.2
mg/l
3.0
2.9
0.32
366
1675
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
404
1980
2.69
49.67
4.4
2.4
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
106
218
5.29
49.52
2.2
2.8
g/l
0.0
0.0
0.50
98
203
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
102
205
5.40
48.88
1.8
2.8
g/l
0.0
0.0
0.49
94
190
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
103
209
5.35
48.84
1.6
1.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
474
2544
2.57
47.94
5.0
2.6
—
—
—
0
0
(3036603) Volume of Urine
53
53
10.48
47.23
2.1
1.4
ml
1632.3
1806.5
—
13
10
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
100
204
5.31
47.10
1.8
2.8
g/l
0.0
0.0
0.00
94
190
(3013826) Glucose [Moles/volume] in Serum or Plasma
727
4815
2.64
46.30
15.4
5.4
mmol/l
6.7
6.7
0.11
710
4512
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
109
244
4.87
46.08
2.0
2.9
g/l
0.2
1.3
3.00
100
221
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
102
223
4.96
44.31
1.8
2.7
g/l
35.5
38.3
3.33
95
195
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
93
189
5.30
43.94
4.5
1.7
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
82
151
5.80
43.11
2.2
2.0
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
118
297
4.35
43.03
5.6
5.6
kpa
9.3
8.8
2.04
113
278
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
54
63
8.98
42.92
3.2
2.8
%
42.2
43.4
0.12
35
17
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
100
221
4.89
42.87
4.6
2.4
ug/min
444.2
123.8
2.57
80
132
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
91
186
5.26
42.70
2.1
1.2
mg/l
15.2
11.1
2.49
83
169
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
107
251
4.63
42.66
2.0
2.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
66
100
6.97
42.04
2.4
2.0
—
—
—
0
0
(3012501) Base excess in Blood by calculation
91
190
5.15
41.67
8.6
4.2
mmol/l
1.8
2.5
1.67
61
124
(3026008) Bacteria identified in Urine by Culture
384
1968
2.50
41.58
3.5
2.7
—
—
—
0
0
(40761535) Cells panel - Urine sediment
180
621
3.29
41.34
10.2
3.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
282
1251
2.71
41.14
2.0
1.7
nmol/l
1276.7
1166.9
0.98
246
972
(3021901) Oxygen saturation in Capillary blood
83
162
5.48
40.97
5.1
2.5
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
108
267
4.39
40.25
1.8
1.5
iu/ml
1.3
0.0
0.82
25
52
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
455
2552
2.38
39.93
4.4
2.7
u/l
62.2
56.6
2.72
447
2379
(3022493) Free Hemoglobin [Mass/volume] in Plasma
44
43
10.63
39.77
7.1
3.5
mg/l
113.0
88.2
0.32
39
37
(3021960) Folate [Moles/volume] in Serum or Plasma
345
1713
2.51
39.69
1.9
1.5
nmol/l
18.5
19.9
0.73
326
1470
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
72
128
5.96
39.22
8.8
6.3
mg/l
11.9
10.5
1.51
66
121
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
35
25
14.45
38.35
3.3
1.4
u/ml
1067.9
1844.2
0.39
35
25
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
55
77
7.48
37.58
1.4
1.2
titre
98.8
178.0
—
8
15
(4035726)
180
657
3.10
37.39
1.6
1.4
—
—
—
0
0
(3017704) Immunofixation for Urine
42
43
10.13
36.73
1.1
1.5
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
114
320
3.87
35.69
7.1
3.3
%
96.8
90.3
2.02
108
304
(40767503) Oxygen content in Capillary blood by calculation
80
175
4.86
34.61
4.9
2.6
%
16.2
16.4
0.11
63
92
(3022313) Gas panel - Capillary blood
146
492
3.28
34.56
8.0
5.2
—
—
—
0
0
(44790047)
63
112
5.92
34.28
2.7
1.7
—
—
—
0
0
(44790048)
63
112
5.92
34.28
2.7
1.7
—
—
—
0
0
(44806118)
63
112
5.92
34.28
2.7
1.7
—
—
—
0
0
(44790049)
63
112
5.92
34.28
2.7
1.7
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
383
2101
2.29
34.24
10.2
3.5
estimate
0.0
0.0
0.91
146
746
(3006184) Hemoglobin [Mass/volume] in Capillary blood
80
177
4.81
34.14
4.1
2.3
g/l
123.4
131.3
1.79
71
129
(3005322) IgE [Units/volume] in Serum or Plasma
157
559
3.13
33.87
2.4
1.3
u/ml
551.4
249.7
0.69
141
520
(3036481) Cortisol [Moles/volume] in Serum or Plasma
197
796
2.81
33.84
2.6
2.2
nmol/l
339.7
361.4
0.89
180
748
(3017181) Myelocytes/100 leukocytes in Blood
181
699
2.92
33.82
6.8
4.8
%
0.8
0.8
0.13
73
220
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
501
3095
2.18
33.10
9.6
3.3
—
—
—
0
0
(3036489) Thrombin time
117
352
3.61
33.04
6.7
2.8
s
23.1
21.5
1.68
109
315
(3025315) Body weight
39
8
50.52
32.71
5.0
3.0
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
91
231
4.22
32.64
4.8
3.4
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
27
16
17.29
32.48
2.5
1.0
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
809
6093
2.41
32.01
7.7
3.9
mm/h
20.1
10.7
33.28
779
5668
(3030905) Polymorphonuclear cells [#/volume] in Blood
73
159
4.86
31.72
3.6
3.4
e9/l
4.4
4.4
0.02
73
159
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
191
787
2.74
31.46
3.3
2.6
u/l
38.1
100.5
0.53
180
687
(3002179) Metamyelocytes/100 leukocytes in Blood
166
635
2.92
31.44
6.2
4.7
%
0.6
0.5
0.14
56
157
(3007164) IgA [Mass/volume] in Serum or Plasma
335
1802
2.26
30.81
2.5
1.4
g/l
3.0
2.4
3.58
254
1131
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
94
255
3.95
30.79
3.1
2.9
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
133
455
3.20
30.58
10.9
13.3
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
73
164
4.71
30.55
4.0
3.8
%
59.2
56.0
1.12
73
164
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
208
909
2.60
30.39
10.1
9.4
kpa
5.0
5.1
1.67
200
873
(3027801) Oxygen [Partial pressure] in Arterial blood
208
910
2.60
30.31
10.1
9.4
kpa
11.6
12.4
1.22
200
877
(3016502) Oxygen saturation in Arterial blood
194
823
2.66
30.08
10.3
10.0
%
94.6
95.6
1.39
186
795
(3002173) Hemoglobin [Mass/volume] in Arterial blood
185
767
2.71
30.01
10.7
10.1
g/l
111.3
123.0
10.12
179
738
(3003396) Base excess in Arterial blood by calculation
207
908
2.59
29.98
10.0
9.5
mmol/l
-0.3
1.1
4.11
167
719
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
22
10
22.45
29.62
8.9
5.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
69
152
4.79
29.56
1.6
1.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
389
2258
2.15
29.28
8.0
2.9
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
105
318
3.56
29.28
2.7
1.9
ug/l
2.1
2.5
0.12
97
284
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
569
3812
2.07
29.09
7.0
4.1
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
156
602
2.87
28.96
15.5
4.0
mmol/l
1.2
1.2
0.07
151
527
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
477
3005
2.07
28.75
2.3
1.9
pmol/l
101.5
95.2
1.82
266
1665
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
36
42
8.84
28.52
1.1
1.0
miu/ml
1488.2
1499.1
0.02
36
42
(3019832) Treponema pallidum Ab [Presence] in Serum
198
873
2.56
28.25
2.4
1.7
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
157
618
2.81
28.05
7.3
5.1
%
0.0
0.2
1.73
59
169
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
45
72
6.48
27.16
5.9
2.2
e6/l
785.6
798.8
—
7
29
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
36
45
8.25
27.00
1.6
1.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
130
471
3.01
26.98
1.8
1.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
379
2241
2.08
26.65
2.2
1.7
mmol/l
1.6
1.5
2.04
357
1898
(3021440) Promyelocytes/100 leukocytes in Blood
161
659
2.70
26.61
7.2
4.9
%
0.1
0.1
0.10
69
202
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
50
95
5.48
25.33
1.9
1.8
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
39
58
6.94
25.19
7.8
1.8
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
39
58
6.94
25.19
7.7
1.8
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
389
2362
2.03
25.11
2.5
2.2
u/l
148.4
265.0
2.04
373
2235
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
53
107
5.16
25.11
1.9
1.7
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
62
143
4.54
25.10
1.3
1.2
u/ml
7.5
1.0
—
6
8
(3044927) Protein electrophoresis panel - Urine
42
68
6.39
25.05
1.1
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
923
7664
2.64
24.86
9.8
5.4
mmol/mol
38.7
39.6
2.17
900
7182
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
65
157
4.35
24.82
1.6
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
65
157
4.35
24.82
1.6
1.4
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
43
72
6.18
24.82
1.9
1.8
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
86
255
3.58
24.70
2.2
1.8
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
452
2909
1.97
24.57
5.6
3.5
u/l
29.8
33.5
2.43
433
2776
(3019550) Sodium [Moles/volume] in Serum or Plasma
997
8644
3.84
24.43
54.1
15.1
mmol/l
139.4
139.6
2.23
989
8433
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
121
446
2.94
24.28
8.9
5.6
mmol/l
23.6
24.6
4.66
112
428
(40761536) Microorganisms panel - Urine sediment
163
704
2.56
24.05
12.7
3.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
100
333
3.21
23.91
2.3
2.7
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
47
89
5.48
23.89
2.5
1.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
22
16
14.02
23.70
2.8
1.9
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
997
8674
3.76
23.66
56.6
15.2
mmol/l
4.1
4.0
36.70
989
8451
(40760892) CBC W Ordered Manual Differential panel - Blood
329
1940
2.01
22.61
9.5
4.8
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
52
114
4.75
22.39
1.7
1.7
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
987
8605
3.31
21.89
44.5
13.2
mg/l
19.6
23.7
5.56
902
6679
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
118
454
2.80
21.82
1.9
1.7
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
38
65
6.03
21.46
1.8
1.9
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
36
60
6.18
20.86
5.4
4.6
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
385
2453
1.90
20.70
1.8
1.4
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
17
10
17.26
20.32
1.4
1.6
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
67
192
3.66
20.22
1.3
1.2
u/ml
7.8
3.0
—
6
18
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
67
194
3.62
19.91
1.3
1.2
u/ml
5.2
16.4
—
8
30
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
54
134
4.19
19.90
1.7
1.6
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
25
7
36.53
19.89
4.0
3.1
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
69
205
3.53
19.73
1.3
1.2
u/ml
34.7
22.6
—
5
8
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
59
161
3.82
19.11
1.6
1.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
50
122
4.25
18.84
1.4
1.7
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
33
56
6.05
18.78
1.2
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
33
56
6.05
18.78
1.2
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
33
56
6.05
18.78
1.2
1.2
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
27
37
7.46
18.72
1.4
1.9
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
58
160
3.78
18.50
1.4
1.2
u/ml
17.1
35.4
—
5
11
(3000093) Morphology [Interpretation] in Blood Narrative
38
75
5.22
18.46
1.3
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
33
57
5.94
18.45
1.2
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
33
57
5.94
18.45
1.2
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
33
57
5.94
18.45
1.2
1.2
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
40
83
4.97
18.37
1.2
1.2
u/l
63.0
61.2
0.06
32
58
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
934
8087
2.36
17.93
6.6
3.8
mmol/l
1.5
1.3
8.54
906
7529
(3002385) Erythrocyte distribution width [Ratio]
868
7310
2.06
17.83
56.1
16.2
%
14.0
13.5
12.08
861
7174
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
59
170
3.62
17.67
1.2
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
47
116
4.19
17.45
1.2
1.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
954
8366
2.48
17.26
7.1
4.1
mmol/l
1.3
1.4
8.87
926
7796
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
915
7890
2.21
17.17
37.6
11.9
ml/min/173m2
58.1
85.8
100.37
846
6496
(3028433) Virus identified in Specimen by Culture
23
29
8.09
17.07
1.5
1.3
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
20
21
9.69
17.04
1.7
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
43
102
4.35
16.81
1.1
1.1
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
19
19
10.17
16.74
1.6
1.9
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
37
78
4.88
16.69
5.4
4.4
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
20
22
9.25
16.47
4.1
1.6
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
963
8519
2.51
16.39
7.4
4.6
mmol/l
2.6
2.8
13.93
936
7936
(3036525) Urea [Moles/time] in 24 hour Urine
20
5
40.77
16.37
2.2
4.4
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
52
145
3.72
16.34
1.4
1.2
u/ml
3.6
5.7
0.47
24
63
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
955
8421
2.43
16.31
7.3
4.2
mmol/l
4.4
4.6
11.12
929
7896
(3044889) 12 lead EKG panel
715
5727
1.77
16.27
4.6
3.6
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
17
15
11.50
16.24
1.6
1.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
248
1480
1.88
15.62
5.2
3.5
ng/l
185.8
544.6
2.50
198
1095
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
37
83
4.58
15.51
2.3
2.7
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
291
1831
1.81
15.45
4.4
1.9
mg/l
1.6
1.1
1.54
243
1381
(21494814) CD8 cells/100 lymphocytes in Specimen
20
24
8.48
15.42
2.7
2.1
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
41
102
4.14
15.08
2.5
2.5
pg
31.7
33.2
1.26
41
102
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
18
20
9.14
14.69
2.9
1.6
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
37
87
4.37
14.63
1.4
1.4
g/l
28.3
31.5
0.67
32
74
(3009871) Measles virus Ab [Titer] in Serum
22
32
7.00
14.46
1.9
1.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
82
324
2.66
14.33
1.2
1.2
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
70
258
2.84
13.97
1.4
1.3
titre
43.8
104.8
—
8
21
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
156
823
2.05
13.96
2.9
2.8
g/l
0.2
0.2
0.15
149
771
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
53
167
3.29
13.85
1.5
1.5
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
19
8
24.15
13.81
2.6
1.6
ng/l
211.6
103.0
—
19
8
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
48
143
3.47
13.69
1.4
1.2
u/ml
3.6
3.9
0.04
13
44
(3008152) Bicarbonate [Moles/volume] in Arterial blood
107
490
2.32
13.64
10.1
8.2
mmol/l
23.3
24.4
1.57
101
459
(3019060) Gas panel - Arterial blood
110
511
2.29
13.57
8.1
5.9
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
179
1002
1.95
13.52
7.3
3.2
umol/l
7.1
9.1
0.79
158
884
(3003181) Sodium [Moles/volume] in Urine
43
120
3.69
13.51
2.2
1.7
mmol/l
62.2
61.5
0.03
38
103
(21494434) Karyotype in Bone marrow
33
77
4.39
13.19
1.3
1.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
272
1754
1.74
12.96
9.7
3.4
kg/l
1.0
1.0
0.25
38
247
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
27
54
5.11
12.94
1.5
1.9
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
79
326
2.54
12.65
3.4
1.6
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
997
9142
2.67
12.51
27.1
9.9
u/l
25.9
28.9
8.48
986
8874
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
300
2027
1.67
11.89
4.3
3.1
ng/l
5001.9
1178.5
6.89
266
1705
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
115
574
2.13
11.86
3.5
2.8
ng/l
392.9
171.4
2.30
104
512
(3023199) Leukocytes [#/volume] in Pleural fluid
31
75
4.23
11.85
1.5
1.3
e6/l
1387.3
2424.2
0.92
24
45
(3009214) Lutropin [Units/volume] in Serum or Plasma
78
331
2.46
11.78
3.2
1.6
u/l
10.0
8.0
0.60
61
268
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
15
5
30.39
11.66
3.6
3.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
38
108
3.61
11.65
3.1
3.2
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
17
24
7.18
11.44
2.4
2.0
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
58
217
2.77
11.28
1.8
1.4
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
29
70
4.23
11.12
1.4
1.4
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
28
66
4.33
11.07
1.5
1.1
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
16
9
18.03
10.74
6.4
6.6
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
16
9
18.03
10.74
6.4
6.6
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
14
5
28.34
10.74
1.2
1.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
206
1291
1.74
10.64
3.3
3.0
mmol/l
2.5
2.4
1.80
187
1139
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
40
125
3.29
10.63
2.8
2.2
—
1330.0
—
0
8
(3037692) Legionella sp identified in Specimen by Organism specific culture
19
33
5.84
10.56
1.2
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
41
131
3.22
10.52
3.6
1.9
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
24
52
4.70
10.51
1.3
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
24
52
4.70
10.51
1.4
1.2
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
12
12
10.10
10.45
2.7
4.3
—
—
—
0
0
(3035880) pH of Pleural fluid
20
37
5.49
10.42
1.3
1.3
—
—
—
0
0
(3019225) pH of Specimen
128
697
1.95
10.38
15.9
4.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
170
1022
1.79
10.10
2.1
1.5
—
—
—
0
0
(4268621)
34
99
3.52
10.08
2.2
2.3
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
63
261
2.50
10.03
11.3
8.2
mmol/l
1.5
1.3
0.43
56
223
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
61
250
2.53
9.93
1.3
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
61
250
2.53
9.93
1.1
1.1
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
12
13
9.33
9.88
17.8
4.7
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
22
47
4.76
9.80
1.6
2.0
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
22
47
4.76
9.80
1.6
2.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
42
143
3.02
9.70
1.6
1.3
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
20
40
5.08
9.59
1.4
1.2
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
11
11
10.09
9.55
2.2
2.1
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
13
6
21.91
9.36
6.2
1.0
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
49
186
2.71
9.31
12.9
9.7
mmol/l
104.7
105.6
0.66
42
168
(3039000) Anion gap in Blood
49
186
2.71
9.31
12.9
9.7
mmol/l
13.0
11.3
1.71
42
168
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
397
3002
1.52
9.27
4.4
3.4
ng/l
78.2
45.7
0.78
309
1968
(3028308) Erythrocytes [#/volume] in Pleural fluid
26
67
3.95
9.17
1.3
1.3
e6/l
26195.7
29003.9
0.08
18
33
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
22
50
4.47
9.11
2.9
1.6
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
232
1561
1.62
9.03
1.7
1.7
pmol/l
31628378.3
40995146.6
0.10
215
1327
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
12
5
24.24
8.92
1.6
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
16
28
5.79
8.82
1.0
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
408
3129
1.50
8.79
2.3
2.0
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
703
6020
1.50
8.64
5.8
3.3
u/l
55.3
49.5
1.05
675
5692
(3000570) Elastase.pancreatic [Mass/mass] in Stool
58
249
2.41
8.58
1.5
1.5
ug/g
266.7
284.5
0.29
43
150
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
21
49
4.35
8.43
1.4
1.4
u/ml
23.6
21.6
—
5
9
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
720
6213
1.50
8.38
4.3
3.6
pmol/l
14.6
14.6
0.03
685
5695
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
848
7586
1.60
8.34
5.1
4.2
mu/l
1.9
2.2
0.63
817
7003
(3007930) Methemoglobin/Hemoglobin.total in Blood
69
324
2.21
8.31
10.6
7.0
%
0.9
0.9
0.13
63
303
(3048689) Calprotectin [Mass/mass] in Stool
175
1120
1.67
8.24
2.5
2.7
ug/g
115.9
121.5
0.10
149
909
(3008757) Leukocyte morphology finding [Identifier] in Blood
33
108
3.12
8.18
9.6
3.8
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
973
9050
1.98
8.15
38.4
12.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
39
141
2.83
8.14
2.0
1.5
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
15
27
5.62
8.03
1.1
1.3
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
69
330
2.17
7.95
10.6
7.0
%
1.7
1.6
0.48
63
308
(3045788) Cell count panel - Pleural fluid
22
57
3.92
7.73
1.3
1.4
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
51
217
2.42
7.72
5.0
3.7
umol/l
29.2
36.1
1.81
43
186
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
113
651
1.82
7.68
2.3
2.4
ug/l
4.1
8.2
4.19
98
596
(3024891) Influenza virus A+B Ag [Presence] in Specimen
56
250
2.31
7.62
1.5
1.1
—
—
—
0
0
(3020891) Body temperature
65
309
2.18
7.61
7.7
5.0
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
11
15
7.40
7.56
2.2
1.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
703
6094
1.46
7.54
3.5
3.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
204
1385
1.59
7.54
1.4
1.3
iu/ml
45.2
32.1
0.42
68
423
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
15
29
5.23
7.46
6.6
7.7
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
29
94
3.14
7.32
1.6
1.2
ug/l
5.0
2.8
0.32
24
82
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
15
30
5.06
7.20
1.4
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
893
8175
1.60
7.01
48.0
14.1
%
37.7
40.7
25.97
687
6302
(3022217) INR in Platelet poor plasma by Coagulation assay
141
891
1.67
6.93
35.6
21.3
inr
1.3
1.3
0.13
19
132
(3000475) Leukocytes [#/volume] in Synovial fluid
45
192
2.40
6.80
2.2
1.7
e6/l
14466.3
13028.9
0.13
32
144
(3003327) Ova and parasites identified in Stool by Light microscopy
64
317
2.08
6.77
1.8
1.7
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
19
49
3.93
6.73
1.4
1.1
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
10
14
7.20
6.70
1.0
1.1
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
28
95
3.00
6.57
1.3
1.4
pmol/l
367.0
454.7
0.26
21
78
(3045142) Bone marrow Pathology biopsy report
30
106
2.88
6.56
1.8
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
162
1076
1.60
6.52
1.2
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
18
46
3.96
6.45
2.2
1.4
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
27
92
2.99
6.30
2.0
1.5
%
52.7
61.1
0.35
15
67
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
60
304
2.03
6.00
1.2
1.3
miu/ml
100.5
214.2
2.42
15
141
(43055514) Macroprolactin [Presence] in Serum or Plasma
11
20
5.55
5.81
1.4
1.6
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
13
28
4.69
5.74
6.9
7.6
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
20
60
3.38
5.74
1.6
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
24
81
3.01
5.71
1.5
1.2
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
70
382
1.89
5.67
3.3
1.5
iu/l
17.3
21.9
0.75
58
313
(4306422)
35
146
2.45
5.59
1.1
1.2
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
9
7
12.95
5.58
1.4
1.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
261
1978
1.42
5.50
1.3
1.3
u/ml
3.1
1.7
0.43
67
534
(3022621) pH of Urine by Test strip
81
468
1.79
5.49
5.9
2.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
64
343
1.92
5.48
2.4
2.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
877
8108
1.49
5.41
6.7
4.2
mmol/l
6.0
5.9
0.37
849
7467
(40768806) Pleura Pathology biopsy report
22
73
3.06
5.39
1.3
1.6
—
—
—
0
0
(3004451) EKG impression Narrative
17
48
3.58
5.34
1.4
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
184
1316
1.48
5.24
1.3
1.2
u/ml
8.5
10.4
0.22
51
528
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
16
44
3.68
5.21
1.3
1.1
—
14.8
—
0
5
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
17
49
3.51
5.19
1.2
1.1
ratio
1.1
1.1
—
8
19
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
41
190
2.20
5.18
1.6
1.4
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
14
35
4.04
5.18
1.2
2.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
14
35
4.04
5.18
1.2
2.1
—
—
—
0
0
(3002256) Pathology report gross observation
146
998
1.54
5.16
1.4
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
80
470
1.76
5.13
1.4
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
25
92
2.76
5.13
1.5
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
34
146
2.37
5.12
1.1
1.1
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
21
70
3.04
5.12
1.8
1.4
%
14.3
28.2
1.53
12
51
(3042631) Mycobacterium sp identified in Specimen
26
98
2.69
5.10
2.5
3.1
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
10
19
5.30
5.04
1.2
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
23
82
2.85
5.00
1.2
1.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
25
94
2.70
4.94
1.1
1.3
nmol/l
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
15
41
3.70
4.93
1.5
1.4
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
15
41
3.70
4.93
1.2
2.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
15
41
3.70
4.93
1.2
2.0
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
15
41
3.70
4.93
1.5
1.4
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
15
41
3.70
4.93
1.2
2.0
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
15
41
3.70
4.93
1.2
2.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
17
51
3.37
4.90
1.4
1.2
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
12
28
4.32
4.83
3.7
5.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
21
73
2.91
4.78
1.2
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
21
73
2.91
4.78
1.2
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
21
73
2.91
4.78
1.2
1.7
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
16
47
3.44
4.76
1.3
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
22
79
2.82
4.73
3.9
4.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
36
166
2.21
4.63
1.1
1.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
11
25
4.44
4.57
6.0
1.7
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
12
30
4.03
4.44
1.1
1.0
—
—
—
0
0
(3013512) EKG study
278
2200
1.36
4.41
4.4
3.7
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
15
45
3.37
4.33
1.1
1.1
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
7
6
11.73
4.28
5.3
1.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
31
636
0.47
4.28
1.5
1.4
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
31
3.90
4.26
1.5
1.1
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
19
67
2.87
4.24
2.6
1.4
u/ml
1.0
0.3
0.30
12
31
(3016018) Differential panel - Cerebral spinal fluid
24
96
2.53
4.23
8.0
1.9
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
227
1750
1.38
4.23
1.7
1.6
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
13
36
3.64
4.21
1.2
2.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
13
36
3.64
4.21
1.2
1.2
—
—
—
0
0
(3034426) Prothrombin time (PT)
13
36
3.64
4.21
1.2
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
55
934
0.57
4.16
1.5
1.7
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
33
154
2.18
4.15
1.1
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
136
961
1.48
4.10
1.6
1.7
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
28
124
2.29
3.99
1.5
1.4
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
9
14
6.47
3.99
1.4
1.0
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
28
125
2.27
3.92
1.6
1.6
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
18
65
2.80
3.86
1.1
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
25
107
2.37
3.85
1.0
1.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
67
1057
0.61
3.82
1.3
1.3
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
11
29
3.82
3.81
1.7
2.0
ug/l
71.1
85.2
0.18
11
29
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
6
5
12.06
3.76
1.2
1.0
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
6
5
12.06
3.76
1.5
1.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
24
102
2.38
3.76
13.5
2.0
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
20
79
2.56
3.64
1.5
1.4
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
11
30
3.69
3.64
1.1
1.1
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
7
9
7.82
3.56
1.3
1.0
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
1007
9743
1.75
3.55
63.1
19.1
e9/l
244.7
248.5
1.04
998
9499
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
23
99
2.35
3.52
1.1
1.3
—
—
—
0
0
(3013862) HLA-DP [Type]
6
6
10.05
3.50
1.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
6
6
10.05
3.50
1.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
6
6
10.05
3.50
1.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
6
6
10.05
3.50
1.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
6
6
10.05
3.50
1.0
1.0
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
6
6
10.05
3.50
1.0
1.0
—
—
—
0
0
(3024731) MCV [Entitic volume]
1007
9749
1.74
3.46
62.7
19.0
fl
91.2
90.5
5.00
1002
9625
(3035941) MCH [Entitic mass]
1007
9751
1.73
3.43
62.7
19.0
pg
30.2
30.3
0.74
1002
9626
(3026361) Erythrocytes [#/volume] in Blood
1007
9752
1.73
3.41
63.0
19.1
e12/l
4.3
4.6
39.14
996
9490
(3010813) Leukocytes [#/volume] in Blood
1007
9754
1.73
3.38
63.2
19.1
e9/l
7.6
6.7
1.07
997
9488
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
37
196
1.92
3.38
9.7
1.7
e6/l
249.0
1417.7
0.67
27
163
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
37
196
1.92
3.38
9.7
1.6
e6/l
23.0
25.4
0.03
27
158
(3024263) Appearance of Synovial fluid
13
42
3.12
3.38
2.8
1.8
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
1007
9756
1.72
3.35
63.4
19.2
g/l
128.1
138.5
61.67
1002
9630
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
12
37
3.27
3.35
1.3
1.1
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
6
7
8.61
3.26
1.5
1.0
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
71
459
1.59
3.25
3.8
3.6
pmol/l
4.4
4.7
1.10
60
409
(3022145) Colonoscopy Study observation
127
928
1.42
3.23
1.4
1.3
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
22
97
2.30
3.21
1.9
1.5
mosm/kgh2o
280.2
286.6
0.84
17
75
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
10
28
3.60
3.20
5.9
1.9
e6/l
1664.0
2812.9
—
5
17
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
8
15
5.37
3.19
2.6
1.9
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
44
252
1.78
3.17
1.3
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
44
253
1.77
3.13
1.3
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
30
152
2.00
3.12
6.2
1.9
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
9
20
4.53
3.11
1.2
1.2
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
14
50
2.82
3.09
1.1
1.1
—
43.2
—
0
5
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
11
34
3.26
3.06
1.5
1.1
g/l
0.3
0.3
—
6
27
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
10
29
3.47
3.05
6.2
2.7
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
34
182
1.90
3.03
10.3
1.7
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
13
45
2.91
3.03
8.3
3.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
44
256
1.75
3.02
1.3
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
14
51
2.77
2.99
1.1
1.1
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
5
5
10.04
2.98
1.2
1.0
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
12
40
3.02
2.98
1.0
1.1
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
8
17
4.73
2.92
1.4
1.4
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
24
115
2.11
2.90
3.9
3.0
nmol/l
0.8
0.9
0.63
15
92
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
9
22
4.12
2.88
1.6
1.0
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
9
22
4.12
2.88
1.6
1.1
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
9
22
4.12
2.88
1.4
1.0
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
19
83
2.31
2.85
2.4
3.5
%
64.7
54.9
1.08
13
59
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
137
1040
1.36
2.80
1.6
1.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
50
309
1.65
2.78
2.3
1.9
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
9
23
3.94
2.78
1.4
1.2
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
7
14
5.03
2.73
1.4
1.1
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
28
146
1.94
2.72
1.1
1.0
u/ml
2.7
1.8
—
6
60
(3017732) Neutrophils [#/volume] in Blood
81
564
1.47
2.69
3.2
2.8
e9/l
4.6
4.1
0.90
69
465
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
24
3.77
2.67
1.4
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
9
24
3.77
2.67
1.4
1.1
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
12
43
2.81
2.65
1.3
1.8
—
1021375.0
—
0
6
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
11
38
2.91
2.58
1.5
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
11
38
2.91
2.58
1.5
1.4
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
6
11
5.48
2.54
1.0
1.5
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
6
11
5.48
2.54
1.3
2.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
402
3537
1.22
2.51
3.9
4.5
ug/l
2.2
2.3
0.11
375
3190
(3022689) Creatine [Moles/volume] in Urine
7
16
4.40
2.47
3.0
1.3
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
10
254
0.39
2.46
1.2
1.6
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
17
77
2.23
2.38
1.2
1.2
nmol/l
1.3
1.5
0.37
17
71
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
7
17
4.14
2.36
2.4
1.1
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
14
59
2.39
2.30
1.8
1.5
u/l
4.4
4.3
—
8
28
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
16
72
2.24
2.28
1.3
1.1
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
76
544
1.43
2.22
1.3
1.3
au/ml
28.2
38.6
—
5
25
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
16
73
2.21
2.21
1.3
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
10
36
2.79
2.20
1.1
1.0
—
—
—
0
0
(3000012) Reticulocyte production index
10
36
2.79
2.20
1.6
2.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
26
143
1.84
2.20
1.2
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
52
347
1.52
2.16
11.0
3.2
—
—
—
0
0
(3019174) dRVVT (LA screen)
5
10
5.02
2.07
1.2
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
20
103
1.96
2.06
1.5
1.5
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
7
20
3.52
2.05
1.4
3.4
—
33.3
—
0
8
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
7
20
3.52
2.05
7.0
9.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
47
312
1.53
2.01
1.7
2.4
u/l
3123.5
3524.2
0.05
15
121
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
128
1013
1.30
2.00
1.5
1.5
—
—
—
0
0
(40768441) Liver Pathology biopsy report
15
70
2.16
1.99
1.7
1.5
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
118
926
1.31
1.97
3.1
2.3
nmol/l
12.5
13.5
0.71
109
832
(3048879) Bone marrow aspiration report
7
21
3.35
1.96
1.0
2.5
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
7
21
3.35
1.96
1.1
3.7
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
20
105
1.92
1.96
1.5
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
20
105
1.92
1.96
1.5
1.5
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
26
149
1.76
1.96
1.1
1.1
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
5
11
4.56
1.94
1.6
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
5
11
4.56
1.94
1.6
1.0
—
—
—
0
0
(44806071)
5
11
4.56
1.94
1.0
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
20
106
1.90
1.91
1.5
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
20
106
1.90
1.91
1.5
1.5
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
12
52
2.32
1.88
1.8
2.3
ug/min
424.2
227.1
—
5
7
(4024509)
12
52
2.32
1.88
4.4
1.3
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
17
3.54
1.84
1.0
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
65
471
1.41
1.82
1.4
1.3
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
9
35
2.58
1.80
1.1
1.2
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
7
23
3.06
1.80
2.3
2.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
43
288
1.51
1.79
2.0
1.7
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
8
29
2.77
1.79
1.5
1.2
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
6
18
3.35
1.75
1.2
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
6
18
3.35
1.75
1.5
1.2
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
6
18
3.35
1.75
1.0
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
13
61
2.15
1.72
1.1
1.1
—
—
—
0
0
(3022229) Phosphate [Moles/volume] in Urine
5
13
3.86
1.71
1.4
3.0
mmol/l
19.9
25.3
—
5
13
(1617658) Protocol used for examination of sentinel lymph nodes
0
46
0.00
1.71
0.0
1.1
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
48
0.00
1.70
0.0
3.7
—
52.1
—
0
48
(4094501)
35
228
1.55
1.67
1.0
1.1
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
15
76
1.99
1.65
4.5
4.7
u/ml
29.0
52.0
—
6
25
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
5
14
3.58
1.61
1.0
1.3
umol/24h
1.1
2.1
—
5
14
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
17
91
1.88
1.61
1.1
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
19
106
1.81
1.59
1.5
1.5
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
12
57
2.12
1.55
1.1
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
12
57
2.12
1.55
1.1
1.1
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
10
44
2.28
1.53
2.9
3.8
ug/l
1.5
1.6
—
10
39
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
43
300
1.45
1.51
1.5
1.7
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
27
170
1.60
1.50
1.7
1.5
—
—
—
0
0
(4027681)
12
59
2.05
1.44
1.4
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
17
96
1.78
1.39
1.5
1.1
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
7
29
2.42
1.39
1.0
1.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
23
142
1.63
1.39
2.1
1.7
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
111
911
1.24
1.35
17.8
6.5
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
24
2.51
1.30
1.0
1.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
12
62
1.95
1.28
1.3
1.3
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
9
45
2.01
1.23
1.9
1.3
nmol/l
139.8
152.6
—
9
45
(3013247) Albumin in CSF/Albumin in Serum or Plasma
5
19
2.64
1.21
1.4
1.0
mg/g
4.7
5.8
—
5
19
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
5
19
2.64
1.21
1.0
1.0
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
26
173
1.52
1.18
2.3
1.6
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
15
87
1.73
1.15
1.2
1.0
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
5
20
2.51
1.15
1.4
1.0
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
10
183
0.54
1.12
1.7
1.5
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
7
30
2.34
1.12
1.4
2.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
307
3356
0.88
1.12
3.8
2.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
36
490
0.73
1.10
1.0
1.0
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
7
31
2.27
1.10
1.4
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
15
89
1.70
1.08
1.1
1.0
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
85
697
1.24
1.08
1.2
1.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
23
337
0.68
1.07
1.7
3.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
10
179
0.55
1.05
1.7
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
10
178
0.56
1.04
1.7
1.4
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
5
22
2.28
1.03
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
5
22
2.28
1.03
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
5
22
2.28
1.03
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
5
22
2.28
1.03
1.0
1.1
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
7
34
2.07
1.03
1.1
1.4
nmol/l
82.7
116.7
—
7
25
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
29
206
1.42
0.99
1.4
1.6
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
10
54
1.86
0.96
1.3
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
47
365
1.30
0.94
1.1
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
37
487
0.75
0.94
1.4
1.6
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
14
220
0.63
0.92
1.6
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
14
220
0.63
0.92
1.6
1.4
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
28
2.15
0.91
1.5
3.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
28
2.15
0.91
1.5
3.0
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
14
219
0.63
0.91
1.6
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
14
219
0.63
0.91
1.6
1.4
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
6
29
2.07
0.89
1.2
1.2
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
6
29
2.07
0.89
1.0
1.0
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
15
95
1.59
0.87
1.3
1.1
—
—
—
0
0
(4010399)
69
569
1.23
0.86
1.5
1.4
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
8
44
1.82
0.86
1.6
3.6
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
18
121
1.50
0.83
1.4
1.5
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
6
32
1.88
0.82
1.5
2.4
u/l
182.3
193.5
—
6
32
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
87
740
1.19
0.81
2.9
4.5
ug/l
40.6
29.9
0.14
71
612
(4034850)
33
250
1.33
0.81
15.6
9.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
15
224
0.66
0.80
2.2
3.7
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
11
66
1.67
0.79
1.9
1.6
g/l
0.9
1.0
0.44
11
66
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
12
74
1.63
0.78
1.4
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
16
233
0.68
0.77
1.5
1.5
—
—
—
0
0
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
0
28
0.00
0.76
0.0
1.3
—
26.2
—
0
23
(3016879) Cocaine [Presence] in Urine
36
458
0.78
0.75
1.5
2.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
39
489
0.79
0.73
1.5
2.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
30
229
1.32
0.71
2.7
1.7
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
18
252
0.71
0.71
1.6
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
39
487
0.79
0.71
1.5
2.5
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
15
101
1.49
0.70
1.3
1.0
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
39
483
0.80
0.67
1.5
2.5
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
7
44
1.59
0.65
1.0
1.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
39
481
0.80
0.65
1.5
2.4
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
8
50
1.60
0.61
2.1
3.3
—
—
—
0
0
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.2
—
1.9
—
0
15
(3000492) Spirometry study
103
916
1.14
0.58
1.4
1.4
—
—
—
0
0
(4211845)
6
35
1.72
0.57
1.7
2.8
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
27
211
1.29
0.57
1.1
1.1
u/ml
4.6
2.8
0.18
14
97
(40768800) Prostate Pathology biopsy report
15
207
0.72
0.57
1.0
1.2
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
10
65
1.54
0.55
1.2
1.1
u/ml
0.5
0.6
—
5
27
(3035320) C reactive protein [Mass/volume] in Body fluid
9
60
1.50
0.54
3.0
1.9
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
6
39
1.54
0.53
4.0
2.3
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
6
40
1.50
0.51
1.2
1.4
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
11
157
0.70
0.51
4.6
5.5
umol/l
311.8
363.1
0.74
11
142
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
10
68
1.48
0.47
1.3
1.7
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
7
48
1.46
0.47
2.4
2.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
112
1227
0.90
0.45
1.8
2.0
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
24
193
1.25
0.43
1.0
1.1
u/ml
5.2
8.1
0.37
14
109
(44813793)
8
56
1.43
0.42
1.3
1.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
5
32
1.57
0.42
1.4
3.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
5
32
1.57
0.42
1.2
1.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
295
2813
1.07
0.42
3.4
4.0
%
27.8
21.1
7.29
134
1230
(3043410) Blood group antigens tested for on Red Blood Cells
5
33
1.52
0.41
1.8
1.3
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
5
33
1.52
0.41
1.0
1.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
23
186
1.24
0.40
1.0
1.1
u/ml
0.5
1.3
0.61
13
93
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
8
60
1.34
0.40
2.1
1.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
103
1122
0.91
0.39
1.7
1.9
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
33
388
0.85
0.39
1.5
2.7
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
5
78
0.64
0.35
1.4
1.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
6
42
1.43
0.35
1.7
2.4
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
13
99
1.32
0.35
4.0
2.7
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
103
952
1.09
0.34
5.9
4.2
%
31.2
31.2
0.01
89
663
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
12
91
1.32
0.34
4.1
2.3
mg/l
23.4
20.2
—
7
24
(3013139) Helicobacter pylori Ag [Presence] in Stool
45
508
0.88
0.33
1.1
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
33
373
0.88
0.26
2.0
1.8
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
12
149
0.80
0.26
1.0
1.3
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
9
73
1.23
0.25
1.4
1.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
14
114
1.23
0.25
1.4
1.4
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
10
78
1.28
0.24
1.1
1.5
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
5
38
1.32
0.23
2.0
2.4
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
5
38
1.32
0.23
4.0
4.8
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
126
1326
0.94
0.23
1.7
1.9
%
1.8
1.5
2.38
111
1179
(3003740) Influenza virus B Ag [Presence] in Specimen
21
181
1.16
0.22
1.1
1.1
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
2.7
—
72.4
—
0
11
(3042517) Benzodiazepines panel - Urine
0
11
0.00
0.21
0.0
3.1
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool
0
10
0.00
0.21
0.0
2.8
—
138.0
—
0
10
(3002523) Influenza virus A Ag [Presence] in Specimen
21
182
1.16
0.21
1.1
1.1
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
19
164
1.16
0.20
1.3
1.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
20
229
0.87
0.20
1.5
1.4
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
17
147
1.16
0.18
3.0
3.2
u/ml
43.9
33.0
0.08
17
140
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
60
563
1.07
0.17
1.3
1.2
iu/ml
105.2
156.4
0.56
20
227
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
9
79
1.14
0.15
1.8
2.0
—
—
—
0
0
(4146454)
9
83
1.09
0.14
3.4
2.7
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
11
94
1.17
0.13
1.0
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
9
108
0.83
0.13
1.1
1.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
11
127
0.86
0.12
1.1
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
20
181
1.11
0.12
7.2
4.2
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
5
47
1.06
0.09
10.8
7.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
6
55
1.09
0.09
1.0
1.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
57
593
0.96
0.08
1.9
1.9
—
—
—
0
0
(4281824)
6
56
1.07
0.08
1.7
1.3
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
7
64
1.09
0.08
1.1
1.1
—
1.5
—
0
9
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
40
382
1.05
0.07
1.6
1.5
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
19
176
1.08
0.07
1.3
1.2
—
—
—
0
0
(1002224) Polysomnography panel
45
432
1.04
0.07
1.0
1.1
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
10
89
1.12
0.07
1.2
1.0
mg/l
257.3
274.9
—
10
80
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
21
199
1.06
0.04
1.3
1.9
iu/l
4.1
5.5
—
5
68
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
49
478
1.03
0.03
1.5
1.8
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
15
141
1.06
0.03
1.3
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
206
2075
0.99
0.03
2.5
2.8
ug/l
0.9
0.7
1.86
151
1272
(44816559) Phosphatidylethanol [Mass/volume] in Blood
21
218
0.96
0.02
1.7
1.3
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
198.0
—
0
5
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
6.3
—
0
6
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
14.5
—
0
5
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
0
6
0.00
0.00
0.0
11.0
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
7
76
0.92
0.00
1.1
1.9
—
—
—
0
0
(3018081) Beta-2-Microglobulin [Mass/volume] in Urine
0
6
0.00
0.00
0.0
1.8
—
8.7
—
0
6
(3003721) Smooth muscle Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
7
70
1.00
0.00
2.0
1.4
—
80.6
—
0
5
(3022670) pH of Venous cord blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
36.1
—
0
8
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
8.5
—
19.5
—
0
8
(4198724)
5
55
0.91
0.00
1.6
1.7
—
—
—
0
0
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
0
8
0.00
0.00
0.0
1.0
—
168.0
—
0
8
(3006270) Folate [Moles/volume] in Blood
5
57
0.88
0.00
1.2
1.1
nmol/l
373.0
401.7
—
5
48
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
9.6
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
8
0.00
0.00
0.0
4.6
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
9
90
1.00
0.00
1.9
1.8
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: D3_IMMUNEMECHANISMNAS – Other and unspecified disorders involving the immune mechanism, not elsewhere classified
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).